Wound Management
Adtec SteriPlas featured in conference presentations for 2019
Adtec Healthcare is excited to attend and support the clinicians presenting at the following conferences for 2019:
The European Conference on Controversies in Diabetic Foot Management conference in Vienna, 2nd – 3rd May 2019 (https://www.diabeticfoot-europe.com/).
Mr Keith Cutting will be conducting an oral presentation on Friday 3rd May at 14:00. His presentation is titled, “Interim Results from Currently Running Study on the Treatment of Biofilm Infection in Diabetic Foot Ulcers Using Gas Plasma”.
The ISDF 2019 conference in The Netherlands, 22nd – 25th May 2019 (https://diabeticfoot.nl/).
Dr Aye Aye Thant from Kettering General Hospital NHS Foundation Trust will be conducting a poster presentation on “Adtec Cold Plasma Treatment to Assist in Treating Diabetic Foot with Multi Resistant Infection”. This will be presented on Wednesday 22nd May from 12:10.
The European Wound Management Association (EWMA) conference in Gothenburg, Sweden, 5th – 7th June 2019 (https://ewma.org/ewma-conference/2019/). Presenting clinical evidence at this conference will be:
Maurice Moelleken from the Universitätsklinikum Essen, Germany. Maurice’s oral presentation on “Prospective RCT to validate the interval of cold atmospheric plasma treatment for reduction of bacterial load, wound area and pain in patients with chronic wounds” will be presented on 6th June at 08:50am.
Dr Michael Pierides from Kettering General Hospital NHS Foundation Trust will have an e-poster at the EWMA conference. His poster, “The Gas Plasma Medical Device: A Novel Therapy in Treating Non-Resolving Infected Diabetic Foot and Leg Ulcers” can be viewed throughout the conference.
Dr Heinrich Rotering from the Universitätsklinikum Münster, Germany will be conducting a poster presentation, “Cold Plasma and Advanced Negative Pressure Wound Treatment – Long Term Follow Up of Treated Infected Implants in Cardiac Surgery”, on 6th June between 09:42 – 09:45.
The Surgical Infection Society Europe conference in Dublin, Ireland, 26th – 28th June (http://sis-e.org/2019/).
Dr Heinrich Rotering will have a poster at this conference. His poster, “Infection of Cardiovascular Implantable Electronic Devices (CIED) – New Approach with Cold Atmospheric Plasma (CAP)” can be viewed throughout the conference.
Adtec Healthcare staff will be present at these conferences to support the presenting speakers and welcome any meetings. Please get in contact with us at info@adtec.eu.com to secure your meeting in advance.
Gas plasma shows promising results in the treatment of non-healing wounds
Renowned for its ability to successfully treat non-healing wounds, the Adtec SteriPlas is a must have for any dermatology and wound care departments.
This 61-year-old patient with a long-term venous ulcer was stalled from healing and present with Klebsiella oxytoca and Enterobacter cloacae. The patient went through a short treatment programme with our gas plasma medical device to achieve exceptional results. Figures (a) - (b) shows the visual changes of the ulcer throughout the short course of treatment with the Adtec SteriPlas.
At the end of the treatment programme, swabs which would normally have shown signs of bacteria were now sterile, allowing the patient to further progress into full healing.
Interested to hear more? Reach out to us at info@adtec.eu.com
Surgical site infections treated with the Adtec SteriPlas
Surgical site infections (SSIs) are still a severe complication after cardiac surgery with a mortality estimated range of up to 40% of cases. These post-operative wounds are generally associated with longer hospital stay and the delayed or inadequate therapeutic measures can lead to avoidable hospital costs for the healthcare system. The significant cost burden on the hospital for a single SSI case is €36,000. 1
It has already been shown that the Adtec SteriPlas is effective due to its increased penetration depth in SSIs to defeat bacteria even under a layer of biofilm independently to their resistance profile. This includes multi-resistant bacteria that have shown little or no response to antibiotics previously. In combination with advanced negative pressure wound treatment (aNPWT), the Adtec SteriPlas has been praised as a “tissue saving approach” offering patients a favourable treatment method for these complicated and chronic wounds compared to conventional treatment therapies. 2
Studies conducted using the Adtec SteriPlas have shown a significant decrease in the mortality rate coupled with accelerated healing. Patients with infected drivelines such as those with left ventricular assist devices have healed in as quick as 1 week, and patients with sternal SSIs have healed in as quick as 6 days. 2,3
Both patients and doctors have praised the Adtec SteriPlas for its exceptional ability at delivering promising results leading to healing.
Be sure to contact us for more information and to see how our medical device may benefit your patients.
- H. Rotering, Cold atmospheric plasma – New options for infection control in wound management, EWMA 2016.
- H. Rotering, Cold atmospheric plasma and advanced Negative Pressure Wound Treatment – First results of a tissue saving approach for deep surgical site infections, EACTS 2018.
- H. Rotering, Das infizierte Implantat, Komplexe Wundbehandlung – Kaltes atmospherisches Plasma und advanced NPWT in der Herzchirurgie, Chirurgie 2019.
Promising results for the treatment of diabetic foot ulcers using the Adtec SteriPlas
We are excited to show you a recent conference poster presented at the BSAC Spring 2019 conference, submitted by Kettering General Hospital NHS Foundation Trust.
The poster shows the promising results of the using the Adtec SteriPlas on diabetic foot ulcers that are stalled by biofilm. The SteriPlas “is postulated as an alternative for antibiotics for patients where antibiotic therapy is difficult (due to resistance or adverse effects) or as an adjunct treatment for patients with chronic wounds including those with biofilms”.
Contact us at info@adtec.eu.com to learn more about how the Adtec SteriPlas may benefit your non-healing wound patients.
Adtec Europe Ltd introduces new Actinic Keratoses Clinical Trial Results at the European Academy of Dermatology and Venerology Annual Meeting in Paris.
P0736 – Efficacy of cold atmospheric plasma versus diclofenac 3% gel in patients with actinic keratoses/field cancerization: preliminary results of a prospective, randomized, rater-blinded study (ACTICAP).
Leeds Teaching Hospitals NHS Trust joins as a trial centre for current RCT
Adtec Healthcare is excited to announce that Leeds Teaching Hospitals NHS Trust will be joining as a trial centre for our randomised controlled trial to evaluate the efficacy of non-thermal gas plasma on sub-clinical wound infection (biofilm) in patients with diabetic foot ulcers compared to those treated with standard care of dressings. The clinical team will be led by our clinical partners, Mr David Russell, the Podiatry and Vascular Research Teams in the Diabetes Limb Salvage Service at Leeds Teaching Hospitals. The Chief Investigator for the trial is Professor Steven Jeffery from HM Forces, Queen Elizabeth Hospital.
Adtec Healthcare reports new case studies on the successful treatment of long-term chronic ulcers.
Adtec Healthcare reports the successful wound management of patients with long term chronic ulcers at 2 hospitals in Germany and Switzerland. Some of these results are included in case studies on the website. The patients had been suffering from long term chronic ulcers where all other treatments had failed. Treatment with Adtec SteriPlas gas plasma managed the infection and the ulcers progressed to complete healing. Following these encouraging case studies results, it is necessary to do a randomized controlled clinical trial to prove the clinical efficacy and benefits.
Adtec attend the European Wound Management Association (EWMA) Conference in London
Adtec had a successful exhibition at the European Wound Management Association (EWMA) in London in May, previewing the new SteriPlas Wound Management System. The innovative device, using controlled neutral plasma for effective wound management attracted a high degree of interest amongst the delegates.
Come see us at the 18th Annual Congress of the German Society for Wound Healing and Wound Care June 18-20, 2015
Adtec Healthcare are exhibiting at the 18. Jahreskongress Deutsche Gesellschaft für Wundheilung und Wundbehandlung 2015 (Annual Congress of German Society for Wound Healing and Wound Care Association) in Ludwigshafen am Rhein, Germany on June 18-20, 2015.